Navigation Links
Physicians Estimate That if Approved, Ceftobiprole Will Steal Nearly a Third of Zyvox's Patient Share in the Treatment of Nosocomial Pneumonia
Date:9/22/2008

Most Important Factors Driving Nosocomial Pneumonia Prescribing in

Hospitals Are Infectious Disease Consults and ATS/IDSA Guidelines

Arlington Medical Resources and Decision Resources Introduce the New

Hospital Anti-Infectives Insight Series

MALVERN, Penn. and WALTHAM, Mass., Sept. 22 /PRNewswire/ -- Arlington Medical Resources (AMR) and Decision Resources find that over 80 percent of surveyed hospital physicians estimate that if approved, Basilea/Johnson & Johnson's ceftobiprole will steal, on average, nearly a third of Pfizer's Zyvox patient share in the treatment of nosocomial pneumonia. In addition, several product profiles that are analogous to ceftobiprole and other antibiotics were presented to physicians to see how they would compete within the nosocomial pneumonia drug market. The new report entitled Hospital Anti-Infectives Insight Series: Nosocomial Pneumonia found that the ceftobiprole analogue profile is well positioned to compete in this drug market.

"We presented several antibiotic product profiles to physicians we surveyed that are analogous to ceftobiprole, Forest's ceftaroline in combination with a beta-lactamase inhibitor and Theravance/Astellas's telavancin to assess the potential positioning of these agents in the future nosocomial pneumonia market," states John Lebbos, M.D., Vice President of Infectious Diseases at Decision Resources. "Physicians were highly receptive to these profiles -- in fact, 67 percent of physicians indicated that the ceftobiprole analogue profile is well positioned to compete in the large empiric, first-line therapy market for nosocomial pneumonia."

The report also finds that hospital prescribing patterns are mainly driven by an institution's infectious disease consults and by guidelines presented by the American Thoracic Society (ATS) and the Infectious Disease Society of America (IDSA). A hospital's protocol and local guidelines play the next important role.
'/>"/>

SOURCE Arlington Medical Resources; Decision Resources
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Mayo Clinic Physicians Report Findings from Research on Sleep Disorders
2. Bayer Issues Additional Guidance to Physicians on Trasylol(R)
3. Leading Physicians Present Interim Results from Multi-Center Studies of VNUS ClosureFAST Catheter at VEITHsymposium
4. Physicians Will Benefit from Medical Software Advice Website
5. Physicians Reconsider Implications of Enhance Trial
6. US Oncology Affiliated Physicians Make a Strong Showing in ASCO Proceedings
7. AlphaDetail AlphaPulse(TM): Most Practicing Physicians React Positively to FDA Panels Recommendation for Additional Cardiovascular Safety Trials for New Diabetes Medications.
8. Independent Physician Surveys Show if Approved, MF101 Could Become First-Line Treatment for Menopause Symptoms
9. New Data Show Ceftobiprole as Effective as Combination Therapy in Treating Patients With Complicated Skin Infections, Including MRSA
10. New Data Show Ceftobiprole as Effective as Combination Therapy in Treating Patients with Diabetic Foot Infections
11. New Report Offers Hope for Closing Health Gap for African Americans, With Nearly 700 Medicines in Pipeline

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)... MIAMI, Nov. 9 ISTA Phar...d additional results from the Company,s Bepreve(TM...Phase 3 clinical studies. These results were pres...g of the American College of Allergy, Asthma &...a poster presentation titled, "Treatment of Ocular...
(Date:11/9/2009)... INDIANAPOLIS, Nov. 9 Ar...g provider of innovative consumer health care serv...ppointed Stephen Goldsmith to its Board of Directo...d his resignation from the Board. ,, (Photo:...07521 ) ,, Goldsmith is the Daniel Paul Profe...
(Date:11/9/2009)... BETHESDA, Md., Nov. 9 /PRNewswire-Asia/ -- Ch...DX ), a leading independent American provider of W...ple,s Republic of China, today,announced results f...0, which,ended September 30, 2009. , , Financi...r of fiscal 2010 was $38.1 million, flat on, ...
Breaking Medicine Technology:ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the 2009 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI) 2ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the 2009 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI) 3Arcadia Resources Names Stephen Goldsmith to Board of Directors 2Arcadia Resources Names Stephen Goldsmith to Board of Directors 3Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 2Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 3Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 4Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 5Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 6Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 7Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 8Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 9Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 10Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 11China Biotics Inc Appoints New Vice President 14663 1China Biotics Inc Appoints New Vice President 14663 2China Biotics Inc Appoints New Vice President 14663 3Stryker Modifies Its Dividend Policy and Declares Transition Dividend 5877 1PRA International Experts Present a Session at the 8th Annual Partnerships in Clinical Trials 2009 5873 1PRA International Experts Present a Session at the 8th Annual Partnerships in Clinical Trials 2009 5873 2
...ounced today that it,has submitted IND and Special... and Drug Administration (FDA), for its pivotal Ph... stroke patients. D-Pharm plans to initiate the,tr...D and SPA. Recently,D-Pharm also obtained Scientif...) on the development strategy for DP-b99 in Europe...
...stern Time - , , SOUTH SAN FRANCISCO, Calif., Ma... ), a biopharmaceutical company focused on oncolog...quarter ended March 31, 2009, and provided a corpo...f our pivotal Phase 3 SPEAR trial of picoplatin fo...cer, along with the independent Data Monitoring Co...
Other Medicine Technology:D-Pharm Submits Investigational New Drug Application and Special Protocol Assessment to the FDA for Phase III Trial of DP-b99 in Acute Stroke Patients 2D-Pharm Submits Investigational New Drug Application and Special Protocol Assessment to the FDA for Phase III Trial of DP-b99 in Acute Stroke Patients 3Poniard Pharmaceuticals Reports First Quarter 2009 Financial Results and Provides a Corporate Update 2Poniard Pharmaceuticals Reports First Quarter 2009 Financial Results and Provides a Corporate Update 3Poniard Pharmaceuticals Reports First Quarter 2009 Financial Results and Provides a Corporate Update 4Poniard Pharmaceuticals Reports First Quarter 2009 Financial Results and Provides a Corporate Update 5Poniard Pharmaceuticals Reports First Quarter 2009 Financial Results and Provides a Corporate Update 6Poniard Pharmaceuticals Reports First Quarter 2009 Financial Results and Provides a Corporate Update 7Poniard Pharmaceuticals Reports First Quarter 2009 Financial Results and Provides a Corporate Update 8Poniard Pharmaceuticals Reports First Quarter 2009 Financial Results and Provides a Corporate Update 9
(Date:11/9/2009)... Comparison of plans finds differences in mood de...v. 9 (HealthDay News) -- Both a high-fat, low-carb...nd a low-fat, high-carb diet appear to help people...as for mood? Only the low-fat diets will result in...dy in the Nov. 9 issue of Archives of Internal Me...
(Date:11/9/2009)... , Tomorrow may be too la...etes condition, according to TOPS Club, Inc. (Take...upport organization. , (V... when it comes to preventing or improving a diabet...ff Pounds Sensibly), the nonprofit weight-loss sup...
(Date:11/9/2009)... , LEBANON, Tenn., Nov. 9 Hea...oday announced it will host their inaugural Hospit...3-15, 2010 at the Marriott Renaissance Hotel in Na...pecting more than 100 hospital operating room dire...als and health systems in the country. Some of the...
(Date:11/9/2009)... Small study reports some people went from incapa... Nov. 9 (HealthDay News) -- Electrical stimulation...tive treatment for severe depression, say German r...nucleus accumbens area of the brains of 10 people....tem that ensures that people remember good experie...
(Date:11/9/2009)... , CAMBRIDGE, Mass., Nov. 9 ... and capabilities in delivering emergency manageme...ntly awarded contracts to support the work of the ...e of Regional Operations, the National Commission ...politan Area Transit Authority (WMATA). The value...
Breaking Medicine News(10 mins):Health News:To Feel Better, Low-Fat Diet May Be Best 2Health News:To Feel Better, Low-Fat Diet May Be Best 3Health News:Diabetes Prevention Is the Best Remedy, TOPS Medical Expert Says 2Health News:Diabetes Prevention Is the Best Remedy, TOPS Medical Expert Says 3Health News:Health Connect Partners Hosts Hospital O.R. & Surgery Center Conference 2Health News:Brain Stimulation May Ease Treatment-Resistant Depression 2Health News:Abt Associates Expands Emergency Management Support Services To the Federal Government and Washington Metropolitan Area Transit Authority 2
...p hotels are to go dark for an hour on Thursday ev...fight against global warming and turns off its lig...els like the Ritz and key businesses have confirme...adio station and backed by Mayor Ken Livingstone, ...
... drug resistant TB could create an "apocalyptic sc...ed more than 30,000 people.. The new plan ...ons they say are needed to slow the spread of mult...uding disease surveillance, diagnosis and treatmen...
...ed at the Swedish medical university Karolinska In..., help combat the depression and agitation sympto...er of epidemiological studies have shown that eati...3 fatty acids it contains. Some studies also sugge...
... manslaughter for three years. Circuit Judge Weber...and gave her the option of serving some of her se...nkler wife of a Tennessee preacher told the Jurors...Mary Winkler was transferred to an undisclosed men...
... of great importance as scientists believe it play...ruses that cause yellow and dengue fevers diseas...ery year.The genes that make up the immune system ...wly-sequenced genome of the Aedes aegypti mosquito...
...nments on the planet, the airplane, is about to be...ne calls at high altitude. Requests to switch off ...art of the takeoff routine for airline passengers,...one use is both a technical and commercial reality...
Other Medicine News:Health News:Plan to Contain Drug Resistant TB Launched-WHO 2Health News:Domestic Abuse Led Wife Killing Her Preacher Husband 2Health News:Aedes Agypti Mosquitos Immune System Revealed 2Health News:'Hi, can You Hear Me? I'm at 30,000 Feet' 2Health News:'Hi, can You Hear Me? I'm at 30,000 Feet' 3
Sugita Aneurysm Clip L-Shaped w/cvd. (S)
Sugita Aneurysm Clip 45 Angled (M)
Sugita Aneurysm Clip L-Shaped (M)
Sugita Aneurysm Clip Slightly Cvd. (L)
Medicine Products: